AU3192393A - Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy - Google Patents
Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapyInfo
- Publication number
- AU3192393A AU3192393A AU31923/93A AU3192393A AU3192393A AU 3192393 A AU3192393 A AU 3192393A AU 31923/93 A AU31923/93 A AU 31923/93A AU 3192393 A AU3192393 A AU 3192393A AU 3192393 A AU3192393 A AU 3192393A
- Authority
- AU
- Australia
- Prior art keywords
- pyridobenzodiazepiones
- axial myopia
- myopia therapy
- selective antimuscarinic
- antimuscarinic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001022 anti-muscarinic effect Effects 0.000 title 1
- 230000004329 axial myopia Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82349592A | 1992-01-21 | 1992-01-21 | |
US823495 | 1992-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3192393A true AU3192393A (en) | 1993-07-22 |
Family
ID=25238929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31923/93A Abandoned AU3192393A (en) | 1992-01-21 | 1993-01-20 | Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy |
Country Status (10)
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5122522A (en) * | 1989-06-21 | 1992-06-16 | The Trustees Of The University Of Pennsylvania | Treatment and control of ocular development |
US6710051B1 (en) * | 1997-01-06 | 2004-03-23 | Klaus Trier Aps | Screening method |
US9827250B2 (en) * | 2012-07-31 | 2017-11-28 | Johnson & Johnson Vision Care, Inc. | Lens incorporating myopia control optics and muscarinic agents |
WO2016171282A1 (ja) * | 2015-04-24 | 2016-10-27 | 学校法人慶應義塾 | 近視予防剤及び近視進行抑制剤 |
GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
US10845622B2 (en) | 2015-09-15 | 2020-11-24 | Largan Medical Co., Ltd. | Multifocal contact lens and contact lens product |
US12298602B2 (en) | 2015-09-15 | 2025-05-13 | Largan Medical Co., Ltd. | Multifocal contact lens and contact lens product |
CN110308570A (zh) | 2015-09-15 | 2019-10-08 | 星欧光学股份有限公司 | 隐形眼镜产品 |
CN115414357B (zh) * | 2022-08-30 | 2023-09-22 | 天津医科大学眼科医院 | 一种酰胺类化合物在制备防治近视的药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1212742B (it) * | 1983-05-17 | 1989-11-30 | Dompe Farmaceutici Spa | Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica |
ATE147626T1 (de) * | 1989-06-21 | 1997-02-15 | Univ Pennsylvania | Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung |
-
1993
- 1993-01-12 WO PCT/US1993/000241 patent/WO1993013777A1/en not_active Application Discontinuation
- 1993-01-14 EP EP93300208A patent/EP0556947A1/en not_active Withdrawn
- 1993-01-15 IL IL104409A patent/IL104409A0/xx unknown
- 1993-01-18 JP JP5005813A patent/JPH0742231B2/ja not_active Expired - Lifetime
- 1993-01-18 CA CA002087510A patent/CA2087510A1/en not_active Abandoned
- 1993-01-18 TW TW082100297A patent/TW222583B/zh active
- 1993-01-20 ZA ZA93374A patent/ZA93374B/xx unknown
- 1993-01-20 ZA ZA1993374A patent/ZA93384B/xx unknown
- 1993-01-20 CN CN93100697A patent/CN1074606A/zh active Pending
- 1993-01-20 AU AU31923/93A patent/AU3192393A/en not_active Abandoned
- 1993-01-20 MX MX9300250A patent/MX9300250A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1074606A (zh) | 1993-07-28 |
CA2087510A1 (en) | 1993-07-22 |
EP0556947A1 (en) | 1993-08-25 |
JPH06206820A (ja) | 1994-07-26 |
TW222583B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1994-04-21 |
ZA93384B (en) | 1993-08-23 |
JPH0742231B2 (ja) | 1995-05-10 |
ZA93374B (en) | 1993-08-23 |
WO1993013777A1 (en) | 1993-07-22 |
IL104409A0 (en) | 1993-05-13 |
MX9300250A (es) | 1993-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2464195A (en) | Method of performing laser therapy | |
AU3278995A (en) | Catheter sleeve and method of use | |
AUPN698495A0 (en) | Improved therapeutic formulation and method | |
AU3497395A (en) | Irradiation catheter and method of use | |
AU5163193A (en) | Method and apparatus for corneal reprofiling | |
AU643420B3 (en) | Improved wheel and method of forming same | |
AU7014296A (en) | Method and apparatus for alleviating cardioversion shock pain | |
AU4139196A (en) | Method and composition for antiviral therapy | |
AU2358895A (en) | Medical electrode and method | |
AU2469795A (en) | Liquid treatment method and system | |
AU7968894A (en) | Pacemaker and method of fabrication | |
AU5218593A (en) | Method of milling | |
AUPN271295A0 (en) | Method of treatment | |
AU5960394A (en) | Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases | |
AU2952192A (en) | Highlighting preparation and method of use | |
AU3192393A (en) | Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy | |
AU6253294A (en) | Method and apparatus for enabling intravenous therapy | |
AU7065694A (en) | Catheter and method of use thereof | |
AU5955094A (en) | Methods and compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections | |
AU4805093A (en) | Methods for treatment of enzyme preparations | |
AU1249395A (en) | Topical treatment of ocular photophobia | |
AU3320595A (en) | Workpiece placement system and method of use | |
AU1314995A (en) | Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use | |
AU2992295A (en) | Therapeutic method and compounds of use therein | |
AU5149793A (en) | Method of preparing aminoalkylhydantoins and aminoalkyl-alpha-aminoacids |